InvestorsHub Logo
Followers 16
Posts 1522
Boards Moderated 0
Alias Born 08/09/2011

Re: None

Wednesday, 07/06/2022 9:53:08 AM

Wednesday, July 06, 2022 9:53:08 AM

Post# of 17405
Big pharma loves to buy small companies in early phases of testing products. It's a leverage game. They don't have to shell out much money, and their own experienced staff can bring a product to fruition. Many times, however, those big boys are left holding the bag. Earlier research was faulty, and the FDA was quick to turn up its nose. I just don't get the big boys who have been unable to process a lupus nephritis product. Sure...they're going to spend a bunch of money for Aurinia, but how much did they spend creating failed enterprise?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News